Related Experiment Video
Updated: Aug 17, 2026

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
Soluble T cell receptors: novel immunotherapies
Peter E Molloy1, Andrew K Sewell, Bent K Jakobsen
1Avidex Limited, 57C Milton Park, Abingdon, Oxfordshire OX14 4RX, UK.
Abstract:
T cell receptors are antigen-specific proteins that have evolved to recognize peptide antigens presented by human leukocyte antigen molecules on most cell types. Like antibodies, T cell receptors are produced with huge diversity but, unlike antibodies, T cell receptors are not secreted and do not undergo somatic mutations that increase their affinities for antigen. Recently, however, methods have been developed that enable T cell receptors to be engineered as soluble proteins with extremely high affinities, and fused to various immune-modulator molecules. T cell receptors are now set to unlock a whole new range of targets with key roles in cancer, viral infections, autoimmune diseases and allergies.
Related Concept Videos
Tumor Immunotherapy
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
The Tumor Microenvironment

